Association between Red Blood Cell Transfusion and 30-day Readmission Following Transcatheter Aortic Valve Replacement

References

• Ashton CM, Del Junco DJ, Souchek S, Wray NP, Mansyur CL. The association between quality of inpatient care and early readmission: a meta-analysis of the evidence. Med Care. 1997;35:1044–1059.
   PubMed Web of Science ®Google Scholar
• Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the medicare fee-for service program. N Engl J Med. 2009;360:1418–1428. doi:10.1056/NEJMsa0803563.
   PubMed Web of Science ®Google Scholar
• Curtis JP, Schreiner G, Wang Y, et al. All-cause readmission and repeat revascularization after percutaneous coronary intervention in a cohort of medicare patients. J Am Coll Cardiol. 2009;54:903–907. doi:10.1016/j.jacc.2009.04.076.
   PubMed Web of Science ®Google Scholar
• Wasfy JH, Strom JB, O’Brien C, et al. Causes of short-term readmission after coronary percutaneous intervention. Circ Cardiovasc Interv. 2014;7:97–103. doi:10.1161/CIRCINTERVENTIONS.113.000988.
   Web of Science ®Google Scholar
• Iribarne A, Chang H, Alexander JH, et al. Readmissions after cardiac surgery: experience of the National Institutes of Health/Canadian Institutes of Health research cardiothoracic surgical trial network. Ann Thorac Surg. 2014;98:1274–1280. doi:10.1016/j.athoracsur.2014.06.059.
   Web of Science ®Google Scholar
• Maniar HS, Bell JM, Moon MR, et al. Prospective evaluation of patients readmitted after cardiac surgery: analysis of outcomes and identification of risk factors. J Thorac Cardiovasc Surg. 2014;147:1013–1018. doi:10.1016/j.jtcvs.2013.10.066.
   PubMed Web of Science ®Google Scholar
• Shahian DM, He X, O’Brien SM, et al. Development of a clinical registry-based 30-day readmission measure for coronary artery bypass grafting surgery. Circulation. 2014;130:399–409. doi:10.1161/CIRCULATIONAHA.113.007541.
   PubMed Web of Science ®Google Scholar
• Cassel CK, Conway PH, Delbanco SF, Jha AK, Saunders RS, Lee TH. Getting more performance from performance measurement. N Engl J Med. 2014;371:2145–2147. doi:10.1056/NEJMp1408345.
   Web of Science ®Google Scholar
• Horwitz LI, Partovian C, Lin Z, et al. Development and use of an administrative claims measure for profiling hospital-wide performance on 30-day unplanned readmission. Ann Intern Med. 2014;161(Suppl 10):S66–75. doi:10.7326/M13-3000.
   Web of Science ®Google Scholar
• Holmes DR, Nishimura RA, Grover FL, et al. Annual outcomes with transcatheter valve therapy: from the STS/ACC TVT registry. J Am Coll Cardiol. 2015;66:2813–2823. doi:10.1016/j.jacc.2015.10.021.
   Web of Science ®Google Scholar
• Hannan EL, Samadashvili Z, Jordan D, et al. Thirty-day readmissions after transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis in New York State. Circ Cardiovasc Interv. 2015;8:e002744. doi:10.1161/CIRCINTERVENTIONS.115.002744.
   Web of Science ®Google Scholar
• Holmes DR, Brenna JM, Rumsfeld JS, et al. STS/ACC TVT registry. Clinical outcomes at 1 year following transcatheter aortic valve replacement. JAMA. 2015;313:1019–1028. doi:10.1001/jama.2015.1474.
   PubMed Web of Science ®Google Scholar
• Murugiah K, Wang Y, Desai NR, Nuti SV, Krumholz HM. Hospital variation in outcomes for transcatheter aortic valve replacement among medicare beneficiaries, 2011 to 2013. J Am Coll Cardiol. 2015;66:2678–2679. doi:10.1016/j.jacc.2015.10.008.
   Web of Science ®Google Scholar
• Nombela-Franco L, Del Trigo M, Morrison- Polo G, et al. Incidence, causes and predictors of early (<30 days) and late unplanned hospital readmissions after transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2015;8:1748–1757. doi:10.1016/j.jcin.2015.07.022.
   PubMed Web of Science ®Google Scholar
• Kolte D, Khera S, Sardar R, et al. Thirty-day readmissions after transcatheter aortic valve replacement in the United States, insights from the nationwide readmissions database. Circ Cardiovasc Interv. 2017;10:e004472. doi:10.1161/CIRCINTERVENTIONS.116.004472.
   Web of Science ®Google Scholar
• Pack Q, Priya A, Lagu T, et al. Development and validation of a predictive model for short- and medium-term hospital readmission following heart valve surgery. J Am Heart Assoc. 2016;5(9):e003544. doi:10.1161/JAHA.116.003544.
   Web of Science ®Google Scholar
• Chatterjee S, Wetterslev J, Sharma A, Lichstein E, Mukherjee D. Association of blood transfusion with increased mortality in myocardial infarction: a meta-analysis and diversity-adjusted study sequential analysis. JAMA Intern Med. 2013;173:132–139. doi:10.1001/jamainternmed.2013.2512.
   PubMed Web of Science ®Google Scholar
• Doyle BJ, Rihal CS, Gastineau D, Holmes DR Jr. Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention: implications for contemporary practice. J Am Coll Cardiol. 2009;53:2019–2027. doi:10.1016/j.jacc.2008.12.073.
   PubMed Web of Science ®Google Scholar
• Murphy GJ, Reeves BC, Rogers CA, Rizvi SI, Culliford L, Angelini GD. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation. 2007;116:2544–2552. doi:10.1161/CIRCULATIONAHA.107.698977.
   PubMed Web of Science ®Google Scholar
• Kappetein AP, Head SJ, Genereux P, et al. Valve academic research consortium-2. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the valve academic research consortium-2 consensus document. J Am Coll Cardiol. 2012;60:1438–1454. doi:10.1016/j.jacc.2012.09.001.
   PubMed Web of Science ®Google Scholar
• Barreto-Filho JA, Wang Y, Dodson JA, et al. Trends in aortic valve replacement for elderly patients in the United States, 1999-2011. JAMA. 2013;310:2078–2085. doi:10.1001/jama.2013.282437.
   Web of Science ®Google Scholar
• Lindman BR, Stewart WJ, Pibarot P, et al. Early regression of severe left ventricular hypertrophy after transcatheter aortic valve replacement is associated with decreased hospitalizations. JACC Cardiovasc Interv. 2014;7(6):662–673. doi:10.1016/j.jcin.2014.02.011.
   PubMed Web of Science ®Google Scholar
• Frerker C, Schewel J, Schluter M, et al. Emeregncy transcatheter aortic valve replacement in patients with cardiogenic shock due to acutely decompensated aortic stenosis. EuroInterevntion. 2016;11(13):1530–1536. doi:10.4244/EIJY15M03_03.
   Web of Science ®Google Scholar
• Kolte D, Khera S, Vemulapalli S, et al. Outcomes following urgent/emergent transcatheter aortic valve replacement: insights form the STS/ACC TVT registry. JACC Cardioavsc Interv. 2018. doi:10.1016/j.jcin.2018.03.002.
   Google Scholar
• Genereux P, Kodali SK, Green P, et al. Incidence and effects of acute kidney injury after transcatheter aortic valve replacement using the new valve academic research consortium criteria. Am J Cardiol. 2013;111:100–105. doi:10.1016/j.amjcard.2012.08.057.
   Web of Science ®Google Scholar
• Arsalan M, Squiers JJ, Farkas R, et al. Prognostic usefulness of acute kidney injury after transcatheter aortic valve replacement. Am J Cardiol. 2016;117:1327–1331. doi:10.1016/j.amjcard.2016.01.037.
   PubMed Web of Science ®Google Scholar
• Lee DH, Buth KJ, Martin BJ, Yip AM, Hirsch GM. Frail patients are at increased risk for mortality and prolonged institutional care after cardiac surgery. Circulation. 2010;121:973–978. doi:10.1161/CIRCULATIONAHA.108.841437.
   PubMed Web of Science ®Google Scholar
• Rodes- Cabau J, Webb JG, Cheung A, et al. Long-term outcomes after transcatheter aortic valve implantation: insights on prognostic factors and valve durability from the Canadian multi-center experience. J Am Coll Cardiol. 2012;60:1864–1875. doi:10.1016/j.jacc.2012.08.960.
   Web of Science ®Google Scholar
• Urena M, Webb JG, Eltchaninoff H, et al. Late cardiac death in patients undergoing transcatheter aortic valve replacement: incidence and predictors of advanced heart failure and sudden cardiac death. J Am Coll Cardiol. 2015;65:437–448. doi:10.1016/j.jacc.2014.11.027.
   PubMed Web of Science ®Google Scholar
• Himbert D, Vahanian A. Transcatheter aortic valve replacement for patients with heart failure. Heart Fail Clin. 2015;11:231–245. doi:10.1016/j.hfc.2014.12.003.
   Web of Science ®Google Scholar
• Bradley EH, Curry L, Horwitz LI. Hospital strategies with 30-day readmission rates for patients with heart failure. Circ Cardiovasc Qual Outcomes. 2013;6:444–450. doi:10.1161/CIRCOUTCOMES.111.000101.
   PubMed Web of Science ®Google Scholar
• Jack BW, Chetty VK, Anthony D, et al. A reengineered hospital discharge program to decrease rehospitalization: a randomized trial. Ann Intern Med. 2009;150:178–187. doi:10.7326/0003-4819-150-3-200902030-00007.
   Web of Science ®Google Scholar
• Naylor MD, Brooten DA, Campbell RL, Maislin G, McCauley KM, Schwartz JS. Transitional care of older adults hospitalized with heart failure: a randomized, controlled trial. J AM Geriatr Soc. 2004;52:675–684. doi:10.1111/j.1532-5415.2004.52202.x.
   PubMed Web of Science ®Google Scholar
• Aranki SF, Shaw DP, Adams DH, et al. Predictors of atrial fibrillation after coronary artery surgery; Current trends and impact on hospital resources. Circulation. 1996;94:390–397. doi:10.1161/01.CIR.94.3.390.
   PubMed Web of Science ®Google Scholar
• Chopard R, Teiger E, Meneveau N, et al. FRANCE-2 investigators. Baseline characteristics and prognostic implications of pre-existing and new-onset atrial fibrillation after transcatheter aortic valve implantation: results from the FRANCE-2 registry. JACC Cardiovasc Interv. 2015;8:1346–1355. doi:10.1016/j.jcin.2015.06.010.
   PubMed Web of Science ®Google Scholar
• Biviano AB, Nafiz T, Dizon J, et al. Atrial fibrillation is associated with increased mortality in patients undergoing transcatheter aortic valve replacement.: insights form the placement of aortic transcatheter valve (PARTNER) trial. Circ Cardiovasc Interv. 2016;9:e002766. doi:10.1161/CIRCINTERVENTIONS.115.002766.
   PubMed Web of Science ®Google Scholar
• Tchetche D, Van der Boon RM, Dumonteil N, et al. Adverse impact of bleeding and transfusion on the outcome post-transcatheter aortic valve implantation: insights from the Pooled-RotterdAm-Milano-Toulouse In Collaboration plus (PRAGMATIC plus) initiative. Am Heart J. 2012;164:402–409. doi:10.1016/j.ahj.2012.07.003.
   PubMed Web of Science ®Google Scholar
• Escarcega R, Lipinski M, Magalhaes M, et al. Impact of blood transfusions on short- and long-term mortality in patients who underwent transcatheter aortic valve implantation. Am J Cardiol. 2015;115(93e):99. doi:10.1016/j.amjcard.2014.09.046.
   Web of Science ®Google Scholar
• Seiffert M, Conradi L, Terstesse A, et al. Blood transfusion is associated with impaired outcome after transcatheter aortic valve implantation. Catheter Cardiovasc Interv. 2015;85:460–467. doi:10.1002/ccd.25691.
   Web of Science ®Google Scholar
• Nuis RJ, Sinning JM, Rodes-Cabau J, et al. Prevalence, factors associated with, and prognostic effects of preoperative anemia on short- and long-term mortality in patients undergoing transcatheter aortic valve implantation. Circ Cardiovasc Interv. 2013;6:625–634. doi:10.1161/CIRCINTERVENTIONS.113.000409.
   Web of Science ®Google Scholar
• Seiffert M, Conradi L, Gutwein A, et al. Baseline anemia and its impact on midterm outcome after transcatheter aortic valve implantation. Cardiovasc Interv. 2017;89:44–52. doi:10.1002/ccd.26563.
   Web of Science ®Google Scholar